KBM
- Dec 18, 2019
- 1 min read

AORN and SGNA Public Advisory Meeting with FDA

SGNA and AORN leadership recently spoke at the public advisory committee of the FDA to address the nursing perspective and effective solutions regarding the issues with duodenoscope-related transmission of pathogens. Here are the summary sites:

https://www.fda.gov/media/132494/download

https://theinsidetract.sgna.org/Article/ArtMID/385/ArticleID/197/SGNA-and-AORN-on-FDA-and-Duodenoscope-Reprocessing

Recent Posts

See All

Have You Evaluated Your Patient Care Contracts?

This article begins to highlight the need for effective contract performance documentation and evaluation. You must place specific, measurable, attainable, relevant, and timely (SMART) key performanc

Masking in Healthcare Facilities

Recall to Stop High Level Disinfection of Storz Urological Scopes

On April 2021 the Food and Drug Administration (FDA) issued a letter to providers to communicate issues with reprocessed urological scopes by Karl Storz. In April 2022, Karl Storz has issued an urgen

Post: Blog2_Post